hormone (ACTH) from the anterior pituitary (Vale et al., 1981) . A large body of evidence indicates that CRH acts as a physiological mediator of stress-related functions (Aldenhoff et al., 1983; Ehlers et al., 1983; Siggins et al., 1985; Swanson et al., 1986; Conti and Foote, 1995; Sawchenko et al., 1996; Baram and Hatalski, 1998) . CRH has also been demonstrated to be widely distributed throughout the brain (Swanson et al., 1983; Sawchenko and Swanson, 1985; Imaki et al., 1991; Sawchenko et al., 1993) . In several regions, the peptide has been shown to have many of the physiological characteristics of a neurotransmitter (Young et al., 1986; Powers et al., 1987; Valentino and Wehby, 1988; Sawchenko et al., 1993) .
The actions of CRH are mediated via interaction with distinct CRH receptors (Grigoriadis et al., 1996) . Two general members of the CRH receptor family are currently known and consist of membrane-spanning G-protein-coupled molecules. The first, CRF 1 (or CRF-R1), has been cloned and functionally characterized in a number of species (Chang et al.,1993; Chen et al., 1993; Perrin et al., 1993; Palchaudhuri et al., 1998) . This receptor binds CRH with high affinity and is positively linked to adenylate cyclase. Rat CRF 1 is found in the pituitary and the central nervous system (CNS) and is the candidate mediator for many of the neuroendocrine and neuromodulatory effects of CRH (De Souza et al., 1985; Potter et al., 1994; Chalmers et al., 1995; Baram et al., 1997; Radulovic et al., 1998) . The amino acid sequence of mouse CRF 1 is highly similar to that of rat CRF 1 (Vita et al., 1993) . However, recently, Radulovic et al. (1998) showed that CRF 1 is differently glycosylated in rat and mouse, as indicated by a higher molecular weight of mouse CRF 1 protein. These authors, using Western blotting, also suggested that the mouse CRF 1 may not share the regional brain distribution of the rat receptor. The second receptor, CRF 2 , is found in at least three subtypes in human and rat (CRF 2α , CRF 2β , and CRF 2γ ), one of which, CRF 2α is found primarily in the CNS Kostich et al., 1998) .
The distributions of messenger RNAs (mRNAs) of the two CRH receptors in rat brain have been demonstrated using in situ hybridization. Thus, Potter et al. (1994) and Chalmers et al. (1995) described, respectively, the anatomical distribution of CRF 1 mRNA and CRF 2 mRNA in adult rat brain, demonstrating distinct patterns for each of these receptors. Also, significant differences in CRH receptor mRNA distribution have been described in different species (Sanchez et al., 1999) . Importantly, the detailed organization and the fine localization of CRF 1 in rodent brain have not been delineated. In addition, mRNA analysis does not provide information about the intracellular localization of CRF 1 to somata versus processes, or about clustering and synaptic relationships of receptor molecules. Therefore, the goal of the present study was to utilize immunocytochemical methods to provide a detailed, single-cell-resolution description of the distribution of CRF 1 in the mouse brain.
MATERIALS AND METHODS

Animals
Adult male C57 black mice (2 months old) were used in this study. Because the overall goals of this series of studies included understanding the possible regulation of CRF 1 by its ligand, CRH, care was taken to utilize mice of similar genetic make-up in all stages of this effort. Therefore, mice used here were progeny of breeding pairs heterozygous for a null CRH allele (a generous gift from Dr. J Majzoub). Specifically, transgenic mice in whom an allele of the CRH gene has been replaced with a neomyocin resistance gene were crossed back to the C57 background strain for a minimum of 14 generations. Progeny of heterozygous breeding pairs were genotyped by polymerase chain reaction analysis (Muglia et al., 1995) , and those found to possess both alleles of the CRH gene (wild type) were used in this study.
To account for potential variation in CRF 1 distribution or abundance deriving from the specific strain or genetic make-up of these mice, brains from two additional mice from a separate strain (129/Ola or CD1 strain) were also studied, with essentially indistinguishable results (not shown). Mice were born and maintained in a federally approved animal facility, and litter size was culled to six. Mice were kept on a 12-hour light/dark cycle and given free access to food and water. All experiments were carried out according to NIH guidelines for the care of experimental animals, with approval by the institutional animal care committee.
Antiserum generation
A polyclonal anti-CRF 1 antiserum was generated in goat, against a 20-amino acid peptide sequence (Santa Cruz Biotechnology, Santa Cruz, CA). The synthetic peptide antigen, comprising the C-terminus of CRF 1 (SIPTSPTRVSFHSIKQSTAL), corresponds to amino acids 425-444 of human CRF 1 and is identical with amino acids 396-415 of mouse and rat CRF 1 . This sequence differs by three amino acids from the corresponding portion (412-431) of mouse CRF 2 . A search of GenBank and SwissProt data bases revealed no known sequences (aside from CRH receptors of other species) with significant homology to this portion of the CRF 1 receptor. To characterize the antigen interacting with the antiserum further, Western blotting was also carried out. To determine whether cross-reactivity with the CRF 2 receptor occurred at the dilution used in this study (as suggested by the manufacturer), sections of mouse heart, known to express only the CRF 2 receptor, were subjected to immunocytochemistry in parallel with brain sections.
Western blotting
Brains were rapidly dissected from adult mice of two strains that were killed by decapitation. The hypothalamus and cerebellum were then separated carefully and homogenized in 50 mM Tris-HCl (pH 7.4, 4°C) containing 150 mM NaCl, 0.25% sodium dodecyl sulfate (SDS), 0.25% sodium deoxycholate, 1 mM EDTA, 2 µg/ml aprotinin, 2 µg/ ml leupeptin, and 2 µg/ml pepstatin. The crude extracts were centrifuged at 14,000 rpm for 20 minutes at 4°C. The supernatant was collected and centrifuged for 10 minutes. The clear supernatant fluid (containing soluble proteins and membrane fraction) was then collected for the following analysis. Protein concentration was determined using BCA Protein Assay (Pierce, Rockford, IL), and 50-µg protein aliquots were size-fractionated on 4-12% Trisglycine gel (Novex, Carlsbad, CA) at 120 V for 2.5 hours.
After electrophoresis, proteins were transferred to Hybond-ECL membrane (Amersham, Arlington Heights, IL). Nonfat milk (6%) in Tris-buffered saline (25 mM Tris, 0.15 M NaCl, pH 7.2) containing 0.05% Tween-20 (TBS-T) was used for blocking and for dilution of primary and secondary antibodies. The membrane was blocked overnight at 4°C and then incubated for 2 hours at room temperature with the anti-CRF 1 antiserum (1:500). After several washes with TBS-T, the membrane was incubated in horseradish peroxidaseconjugated anti-goat IgG (1:10,000, Jackson ImmunoResearch, West Grove, PA) for 1.5 hours at room temperature. Following rinsing with TBS-T, bound antibody was detected using the ECL detection system (Amersham). For control, the primary antiserum was preadsorbed overnight at 4°C with purified CRF 1 blocking peptide (100 µg/ml; Santa Cruz Biotechnology).
Immunocytochemistry
Care was taken to harvest tissue under relatively stress-free conditions (Yan et al., 1998a,b) . Briefly, mice (n = 4) were undisturbed for at least 24 hours prior to experiments and then deeply anesthetized with sodium pentobarbital (100 mg/kg intraperitoneally) within 45 seconds of initial handling. Mice were then removed to the laboratory and perfused via the ascending aorta with 0.9% saline solution followed by freshly prepared 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB, pH 7.4, 4°C) . Brains were dissected from the skull, postfixed for 4 hours, and immersed in 15%, followed by 25% sucrose for cryoprotection. Brains were blocked in the coronal or sagittal planes and sectioned at 20-µm thickness using a cryostat. In each plane, one in eight matched sections (one in four for the hypothalamic region) were subjected to immunocytochemistry, and an adjacent series of sections was stained with cresyl violet.
For CRF 1 -LI immunocytochemistry, free-floating sections were collected into tissue-culture wells in 0.1 M PB and subjected to standard avidin-biotin complex (ABC) methods (Chen et al., 1998a; Yan et al., 1998a,b) . Briefly, after several washes with 0.01 M phosphatebuffered saline (PBS) containing 0.3% Triton X-100 (pH 7.4, PBS-T), sections were treated for 30 minutes in 0.3% H 2 O 2 in PBS, followed by blockade of nonspecific sites with 2% normal rabbit serum in PBS for 30 minutes. After a 10-minute rinse in PBS, sections were incubated for 48 hours at 4°C with anti-CRF 1 (1:5,000) in PBS containing 1% bovine serum albumin and 2% normal rabbit serum and washed 3 times in PBS-T, 5 minutes each. Subsequently, sections were incubated in biotinylated rabbit-anti-goat IgG (1: 200, Vector, Burlingame, CA) in PBS for 1 hour at room temperature. After washing in PBS-T (3 × 5 minutes), sections were incubated in ABC solution (1:100; Vector) for 2 hours at room temperature. Sections were then rinsed again in PBS-T (3 × 5 minutes). The reaction product was visualized by incubating sections for 8-10 minutes in 0.04% 3,3′-diaminobenzidine (DAB) containing 0.01% H 2 O 2 with or without 0.5% nickel chloride.
Several approaches were used to address the specificity of the immunostaining obtained with anti-CRF 1 . In addition to the Western blotting described above, the specificity of the primary antiserum was also tested by substituting normal goat IgG (1:1,000-5,000; Santa Cruz Biotechnology) for the primary antiserum and by preadsorbing the antiserum overnight with purified CRF 1 blocking peptide (100 µg/ml). The specificity of the second antibody was tested by omitting the primary antiserum during the first incubation. As indicated above, cross-reactivity with CRF 2 was tested by using the antiserum for staining mouse heart tissue, known to express CRF 2 only.
Regional and laminar distribution patterns of CRF 1 -LI were determined by comparison of immunocytochemical sections with adjacent cresyl-violet stained sections and by evaluation of methyl green-counterstained sections. Published nomenclature was used to identify cytoarchitectonic areas in the cortex (Dolorfo and Amaral, 1998) , amygdala (Pitkänen et al., 1997) , hypothalamic paraventricular nucleus (Swanson and Kuypers, 1980; Swanson et al., 1983) , and other regions (Sidman et al., 1971; Paxinos and Watson, 1982) .
Density and intensity of CRF 1 -LI-labeled neurons
The relative density of CRF 1 -ir neurons was assessed with a square lattice system (Chen et al., 1998b) over the entire area examined, using light microscopy at ×400 magnification. Density was expressed as the percentage of positive cells related to total cell number in the region of interest or in a 0.01-mm 2 real area, based on the average value from three fields per section. Generally, three to five sections were counted in every mouse for evaluating CRF 1 -ir neuronal density in each brain structure or nucleus, and the percentage of CRF 1 -ir neurons was calculated by dividing the total number of CRF 1 -ir neurons by the sum of Nissl-stained cells. The intensity of CRF 1 -LI labeling was scored as weak (+), moderate (+ +), intense (+++), or strongly intense (++++).
RESULTS
The specificity of the anti-CRF 1 antiserum was assessed by immunoblotting mouse hypothalamus and cerebellum homogenates ( Fig. 1) . As shown in lanes 1 and 2, the antiserum recognized an approximately 80-kDa protein, in good agreement with the molecular weight of mouse brain CRF 1 protein (Radulovic et al., 1998) . Preadsorption of the primary antiserum with a blocking peptide consisting of the immunogenic epitope (100 µg/ ml) completely abolished the CRF 1 band (Fig. 1, lanes 3 and 4) . The specificity of CRF 1 immunoreactivity was also indicated by the absence of labeled neurons or fibers in brain sections that were stained using antiserum pretreated with the antigenic peptide ( Fig. 2D ). In addition, no staining was observed on the sections when normal goat IgG was substituted for the CRF 1 -directed serum or in the absence of the primary antiserum (not shown). Finally, cross-reactivity with the CRF 2 receptor was excluded by the absence of any signal in mouse heart specimens run in parallel to immunopositive brain sections (not shown).
CRF 1 -LI neurons were widely but selectively distributed throughout the mouse brain. In addition, the intensity of CRF 1 reaction product in positive neurons differed in a neuron-and region-specific manner. In general (but not always; see Fig. 2C ), CRF 1 -LI in most involved brain regions showed a pattern typical of membrane localization and was further characterized as either granular (associated with intensely labeled neurons) or finely punctate (generally present in moderately or weakly labeled cells). A third pattern, a homogenous deposit associated with the plasma membrane, was found in several regions ( Fig. 2A-C) . Notably, intensity of the CRF 1 immunoreaction product was maximal in neocortical pyramidal cells, Purkinje cells, and most positive neurons in the thalamus, hypothalamus, and brainstem nuclei.
The distribution of CRF 1 -LI neurons in the four mouse brains studied in detail was essentially identical, with relatively modest variation in labeling intensity among animals. The following is a description of the distribution of CRF 1 -LI neurons by region.
Telencephalon Table 1 outlines the distribution of CRF 1 -LI in the telencephalon.
Olfactory bulb and tubercle-In the olfactory bulb ( Fig. 3A ), many periglomerular cells were intensely CRF 1 -LI labeled and thus outlined the glomeruli that were unstained. In addition, a few large, multipolar, intensely labeled neurons were observed just beneath the glomerular layer. Mitral cells were moderately or weakly immunoreactive, and some weakly labeled neurons were also present in the external and internal plexiform layers. In addition, some immunoreactive puncta were observed in the internal plexiform layer and, rarely, in the external plexiform layer. The granular layer contained numerous labeled puncta and scattered CRF 1 -LI neurons. The distribution pattern of CRF 1 -LI in the accessory olfactory bulb resembled that found in the main bulb; conversely, most neurons in the anterior olfactory nucleus were CRF 1 -ir. Within the olfactory tubercle ( Fig. 3B ), moderately CRF 1 -LI-labeled neurons were prominent in the pyramidal layer. Scattered large, multipolar, intensely labeled neurons and some medium-size, weakly labeled cells were seen in the polymorphic layer, but none in the plexiform layer. The islands of Calleja contained moderately labeled CRF 1 granular reaction products, whereas neurons in the taenia tecta were moderately immunoreactive.
Cerebral cortex-Neocortical areas contained a large number of CRF 1 -LI neurons, the intensity of which differed substantially across regions. The most intensely labeled neurons occurred in the cingulate cortex and in the somatosensory area of the frontoparietal cortex, followed by the motor area of frontoparietal cortex. CRF 1 -LI neurons in the association areas of the striate and temporal cortices were characterized by moderately intense reaction product. The laminar distribution of CRF 1 -LI-labeled neurons was striking: in the cingulate, frontoparietal, and most other neocortical regions, whereas immunopositive neurons were distributed throughout layers II-VI, maximal intensity of the reaction product was found in layer V, most notably in the frontoparietal cortex motor area (Fig. 3C ). In addition, rare CRF 1 -LI neurons were observed in layer I and in subcortical white matter. Within piriform cortex, moderately labeled CRF 1 -ir neurons were common in both the pyramidal (II) and polymorphic (III) layers, intermingled with a smaller population of intensely labeled cells ( Fig. 3D ). In the entorhinal cortex, many moderately labeled neurons were distributed in layers II and III, accompanied by a scattered population of large, multipolar, intensely labeled neurons. CRF 1 -LI neurons in layers V-VI were moderately labeled ( Fig. 3E ). Perirhinal cortex contained CRF 1 -LI-labeled neurons uniformly throughout layers II and III.
Hippocampal formation-Within the hippocampus, CRF 1 -LI-containing neurons were most prominent in the pyramidal cell layer: the CA1 pyramidal cell layer was rich in moderately labeled puncta and contained several intensely labeled large neurons. CA2 was distinguished by intense or moderate labeling of virtually all pyramidal neurons. In CA3, maximal intensity of CRF 1 -ir was found in CA3a, with a gradual decline over CA3b and a fainter signal over CA3c. Outside the pyramidal layer, only occasional medium-sized, multipolar or fusiform CRF 1 -ir neurons were scattered in the strata oriens, lacunosummoleculare, and radiatum ( Fig. 4A,B ). Within the dentate gyrus, granule cell somata were outlined by a fine mesh of weakly stained puncta, and occasional strongly labeled basketlike neurons were visible. Large, polymorphic, intensely labeled neurons were present in the hilus, whereas little CRF 1 -LI was observed in the molecular layer ( Fig. 4A,C) . Within the subiculum, many pyramidal neurons were intensely labeled ( Fig. 4D ).
Amygdala-Large, intensely labeled neurons were widely distributed throughout the basal nucleus ( Fig. 5A,B ). The staining pattern of the accessory basal nucleus consisted of weakly labeled medium-sized neurons, and this pattern was shared by the medial nucleus: in both nuclei, only a portion of the cell surface typically showed CRF 1 -LI ( Fig. 5C ). Most neurons were immunoreactive in the anterior cortical nucleus, with a similar pattern but lower intensity than in the medial nucleus. In the central nucleus (ACe), weak to moderate CRF 1 -LI labeling was found in both lateral and medial divisions, but with a different staining pattern: whereas immunoreactivity in the lateral division consisted of punctate deposits, the medial division pattern consisted of crescent-shaped contours (similar to the pattern found in medial and accessory basal nuclei; Fig. 5D ). Finally, weakly labeled neurons were present in the lateral nucleus. Within the bed nucleus of stria terminalis (considered a part of the "extended amygdala"), moderately labeled puncta were abundant in both medial and lateral areas (not shown).
Basal forebrain-Most lateral septal nucleus neurons showed intense CRF 1 -LI. Interestingly, each subnucleus demonstrated a distinct immunoreactivity pattern ( Fig. 6A -C): the dorsal region contained many medium-size neurons with granular CRF 1 -LI deposits (Fig. 6B ), whereas the intermediate region also contained (medially) cells with a fine punctate CRF 1 -LI pattern and short processes. A third pattern, consisting of large granular deposits without a distinct neuronal contour, was observed in the ventral region of this septal nucleus (Fig. 6C ). The medial septum contained many large, intensely or moderately labeled neurons, whereas multipolar, intense CRF 1 -LI-labeled magocellular neurons were abundant in both the horizontal and vertical limbs of the diagonal band of Broca (Fig. 6D ).
Basal ganglia-Most CRF 1 -LI neurons in the striatum (caudate-putamen) were weakly labeled and were accompanied by scattered medium-sized, intensely labeled cells ( Fig. 6E) . A similar but more intense labeling pattern was evident in the nucleus accumbens (Fig. 6F ). The fundus striati and ventral endopiriform nucleus were characterized by abundant, moderately CRF 1 -LI neurons. A population of larger, multipolar or fusiform process-possessing neurons was encountered in the globus pallidus and the ventral pallidum ( Fig.  6F ), whereas the entopeduncular nucleus contained moderate numbers of intensely CRF 1 -LI cells.
Diencephalon Table 2 outlines the distribution of CRF 1 -LI neurons in the diencephalon.
Habenula-Small neurons in medial habenula were intensely CRF 1 -LI labeled, whereas lateral habenula showed numerous moderately CRF 1 -LI neurons and scattered intensely labeled cells (Fig. 7A ).
Thalamus-The anterior nuclear group demonstrated numerous CRF 1 -LI strongly labeled neurons (in the anterodorsal and anteromedial nuclei) and moderately labeled ones (anteroventral nucleus) ( Fig. 7A ). Many neurons with intensely labeled somata and short processes were found in the mediodorsal nucleus. In the lateral nuclear group, the dorsal and posterior nuclei contained multipolar or triangular intensely CRF 1 -LI neurons possessing short processes. In the ventral group, intensely labeled neurons were abundant in the lateral, posterolateral, and posteromedial nuclei, as well as in the midline nuclear group (paratenial, paraventricular, and reuniens nuclei) and in the intralaminar nuclear group. In the thalamic reticular nucleus, only weak or moderate CRF 1 -LI was found ( Fig. 7B ).
Hypothalamus-Within hypothalamus, most CRF 1 -LI labeling of neurons was intense, especially in the supraoptic, paraventricular (PVN), ventromedial (VMH), and arcuate nuclei ( Fig. 8A-F) . The medial preoptic area contained numerous highly CRF 1 -LI neurons, reminiscent of those of the amygdaloid medial nucleus, whereas the lateral preoptic nucleus contained triangular or fusiform, moderately labeled cells bearing several short processes. The suprachiasmatic nucleus was characterized by densely immunoreactive neuropil, whereas the retrochias-matic area contained a few weakly CRF 1 -LI-positive neurons in conjunction with scattered intensely CRF 1 -LI-positive puncta. Neurons in the supraoptic nucleus were more strongly immunolabeled than those in the suprachiasmatic nucleus ( Fig.  8D ). Parvocellular neurons of the PVN demonstrated exceptionally strong CRF 1 -LI; in contrast, few positive neurons were present in the magnocellular divisions ( Fig. 8A-C) . In the VMH, neurons were intensely labeled ventrolaterally and moderately labeled in the dorsomedial part, in a granular pattern. Intensity of CRF 1 -ir in the arcuate nucleus was higher than that observed in the VMH (Fig. 8E,F ). Staining intensity of CRF 1 -LI in neurons of the posterior lateral hypothalamic area was mostly weak or moderate. Interestingly, several subependymal neurons in the median eminence showed CRF 1 -LI ( Fig. 8E ).
Subthalamus and geniculate bodies-Subthalamic neurons showed CRF 1 -LI, as did most zona incerta cells (Fig. 7C ). In the lateral geniculate body, neurons were generally intensely labeled dorsally and moderately or weakly labeled in the ventral parts, whereas both parts of the medial geniculate body contained intensely immuno-reactive neurons. Table 3 outlines the distribution of CRF 1 -LI-expressing neurons in the mesencephalon. A large number of CRF 1 -LI-labeled neurons was observed in the tectum. Within layers II-VII of the superior colliculus, these neurons were moderately or weakly immunoreactive, accompanied by a few large, multipolar, deeply labeled cells in the lateral part of layer VI and occasionally in layer VII (Fig. 9A) . The most striking feature of the inferior colliculus was large, multipolar or triangular, strongly CRF 1 -LI neurons in both the cortical and central nuclei, where most medium-sized neurons were moderately stained (Fig. 9B) . Comparison of the dorsal and lateral inferior colliculus cortex revealed a few CRF 1 -LI neurons in the latter.
Mesencephalon
Within tegmental nuclei, labeling intensity was maximal in the ventral (Fig. 9C) , moderate in the laterodorsal, and weak in the dorsal nucleus (Fig. 9C,G) . Neurons in the pedunculopontine-tegmental and reticulotegmental nuclei were strongly labeled. In red nucleus, most large neurons with short processes were intensely labeled (Fig. 9D) . The substantia nigra pars reticulata was characterized by large, multipolar, neurons with intense CRF 1 -LI, whereas the pars compacta contained medium, moderately to intensely labeled cells (Fig.  9E) . Similarly, process-bearing neurons in the interpeduncular nucleus were moderately or intensely labeled. The dorsal raphe nucleus was rich in highly labeled neurons, whereas only modest numbers of intensely stained neurons were observed in the median raphe (Fig. 9G ).
Both the accessory (Edinger-Westphal) and principal oculomotor nuclei contained moderate or intense CRF 1 -LI (Fig. 9F) . Neurons with short processes in the Darkschewitsch nucleus were moderately labeled. The mesencephalic nucleus of the trigeminal nerve showed intense CRF-LI in a granular pattern (see Fig. 11A ). In addition, many medium-sized, moderately labeled neurons were present in the central gray, particularly dorsally.
Pons and medulla
Pontine and medullary raphe nuclei shared the staining pattern of their mesencephalic counterparts. Within the reticular formation, large, multipolar, intense CRF 1 -LI neurons were abundant in the pontine and gigantocellular reticular nuclei, whereas only scattered positive neurons resided in the intermediate and lateral nuclei. The locus coeruleus was rich in multipolar, intensely CRF 1 -LI-labeled neurons (see Fig. 11A ). Dorsal parabrachial nuclei were more intensely stained than ventral ones (see Fig. 11B ). Large, multipolar neurons in superior olive and nuclei of lateral lemniscus were also intensely stained.
Within trigeminal nerve nuclei, large, multipolar neurons in the motor, principal sensory, and spinal subnuclei showed intense CRF 1 -LI. In addition, numerous moderately labeled small and medium cells were found in both principal sensory and spinal nuclei (Fig. 10A ). The facial nucleus was rich in large, multipolar CRF 1 -LI neurons (Fig. 10B ), whereas the vestibular nuclei (medial, lateral, and superior) contained numerous moderately or in-tensely labeled cells (Fig. 10C ). In the cochlear complex, the ventral nucleus had more intense CRF 1 -LI than the dorsal nucleus, the latter containing rare highly labeled neurons and some moderately immunoreactive neurons (Fig. 11C ). Some neurons in vagal, ambiguous, and hypoglossal nuclei showed strong CRF 1 -LI ( Fig. 10D,E) . Weak-to-moderate CRF 1 -LI labeling occurred in medial and lateral divisions of the solitary tract nucleus (Fig. 10F ).
Medium-sized, highly labeled CRF 1 -LI neurons were observed in the medial nucleus of the trapezoid body, in contrast to the occasional, intensely labeled cells of the lateral nucleus (Fig. 11D,E) . In the inferior olive, medium-sized CRF 1 -LI-stained neurons were found (Fig.  11F ).
Cerebellum
Purkinje cells showed intense CRF 1 -LI, in a granular pattern ( Figs. 2A, 11G ), whereas the granular layer contained only scattered intensely labeled neurons accompanied by abundant weakly labeled puncta. Large, multipolar neurons in the deep cerebellar nuclei were intensely stained, whereas the cerebellar white matter was devoid of CRF 1 -LI.
DISCUSSION
The current immunocytochemical study describes the distribution of CRF 1 -LI throughout the mouse brain. The results indicate that 1) CRF 1 -LI is generally localized to the cell membrane and is further characterized as granular, punctate, or homogenous deposits; 2) CRF 1 -LI-labeled neurons are morphologically heterogeneous both within and among brain structures; 3) CRF 1 -LI is widely and selectively distributed in discrete regions of the mouse brain, in a pattern that-with notable exceptions-generally conforms to that of CRF 1 mRNA; and 4) a gradient of CRF 1 -LI labeling intensity exists, with the highest found in certain hypothalamic nuclei, neocortex, septum, basal amygdala, thalamus, select brain stem regions, and cerebellar Purkinje cells. CRF 1 immunoreaction product was generally localized to the cell membrane. This result is consistent with evidence indicating that this receptor is a G-protein-coupled, membranebound protein (Chang et al., 1993; Perrin et al., 1993; Castro et al., 1996) . Of the several patterns of CRF 1 -LI observed in this study ( Fig. 2A-C) , some may signify receptor clustering (granular and punctate deposits). In addition, the spectrum of cellular distribution patterns of CRF 1 -LI was remarkable, both within a given nucleus as well as among regions. Most commonly, punctate or granular CRF 1 -LI outlined a neuronal profile consisting of the soma with or without dendritic processes. In some cases, CRF 1 -LI outlined only part of the cell surface, suggesting somatic innervation, perhaps by a spatially discrete bundle of axons (e.g., the climbing fiber innervation of cerebellar molecular layer neurons). Interestingly, numerous CRF 1 -LI-labeled puncta were observed in certain regions such as the granular layers of the olfactory bulb and cerebellum, suggesting a presynaptic location of CRF 1 . Thus, the findings of this study are consistent with a potential for not only the post-but also presynaptic location of CRF 1 . However, electron microscopic (EM) studies are required to demonstrate the presence of presynaptic CRF 1 definitely.
In general, neurons with CRF 1 -LI were observed in target regions of CRH-expressing local circuit and projection neurons. An eloquent example of this notion was evident in the amygdala. In the ACe, CRH-containing terminals are abundant and have been shown to arise from cell bodies located in the lateral hypothalamus and dorsal raphe, as well as from intrinsic CRH neurons in the ACe (Swanson et al., 1983; Uryu et al., 1992) . In the present study, we observed that essentially all ACe neurons were CRF 1 -LI positive. This indicates that in the ACe, CRF 1 -ir neurons may be innervated by CRH-expressing cells originating both within and outside the amygdala. Interestingly, the density and intensity of CRF 1immunoreaction product in the ACe were high. In contrast, CRF 1 mRNA expression in the ACe has been found to be modest (Potter et al., 1994; Chalmers et al., 1995; Avishai-Eliner et al., 1996) . Thus, it may be suggested that the CRF 1 -LI in the ACe may originate in the somata of other nuclei (e.g., lateral amygdala; Pitkänen et al., 1997) and transported to ACe. An additional, intriguing possibility is that the ACe may contain novel, as yet uncharacterized, ligand for this receptor (e.g., Weninger et al., 1999) . Whereas levels of CRF 1 -LI and mRNA are somewhat discordant in the ACe, the results of the current studyshowing intense labeling of magnocellular neurons in basal nucleus-are in accordance with levels of CRF 1 mRNA expression and CRH receptor binding in this nucleus (De Souza, 1987; Potter et al., 1994; Chalmers et al., 1995; Avishai-Eliner et al., 1996) . CRF 1 -LI was localized to regions receiving CRH-containing projections from the amygdala. Indeed, the amygdala is considered an origin of major CRH-containing pathways, emanating from the ACe, the major output nucleus for amygdaloid projections to the brainstem and hypothalamus (Swanson et al., 1983; Sakanaka et al., 1986; Gray and Bingaman, 1996; Pitkänen et al., 1997) . CRH neurons in ACe have been shown to project to the bed nucleus of the stria terminalis (BNST), lateral hypothalamus, midbrain central gray, parabrachial nucleus, mesencephalic nucleus of the trigeminal nerve, mesencephalic reticular formation, solitary tract nucleus, and vagal nucleus (Veening et al., 1984; Sakanaka et al., 1986; Moga et al., 1989) . In view of the widespread CRH projections from the ACe, it is not surprising that abundant CRF 1 -LI-expressing neurons are observed in the current study. Indeed, the distribution of CRF 1 -LI-labeled neurons demonstrated in this study highly overlaps that of target regions of CRH-expressing projections from the ACe. An additional CRH-expressing group of projection neurons originates in the amygdaloid corticomedial nucleus, innervating the VMH (Sakanaka et al., 1986) . Accordingly, the current study demonstrated numerous CRF 1 -LI-labeled neurons in VMH.
CRF 1 -LI-positive neurons were abundant in most cholinergic nuclei of the basal forebrain, including the septum and the diagonal band of Broca. Interestingly, we found high levels of CRF 1 -LI in both the lateral and medial septum, whereas reports on the distribution of CRF 1 mRNA have suggested a preferential localization to the medial septum . In addition, within the lateral septum, regional differences were evident in the cellular pattern of CRF 1 -ir, implying regional specificity in the localization and perhaps physiological functions of this receptor. Thus, the demonstration of CRF 1 -LI-positive neurons in cholinergic nuclei afferent to the hippocampal formation may suggest that the receptor participates in modulation of cholinergic input to the hippocampus.
The current study demonstrated a rich array of CRF 1 -LI-expressing neurons in the hippocampal formation. CRH has been shown to influence directly synaptic function in hippocampal CA1 (Aldenhoff et al., 1983; Smith and Dudek, 1994) and CA3 (Hollrigel et al., 1998) and to excite hippocampal neurons both in vivo (Baram et al., 1997) and in vitro (Aldenhoff et al., 1983; Smith and Dudek, 1994; Hollrigel et al., 1998) . These effects may be important in modulating learning and memory processes (Liang and Lee, 1988; Lee et al., 1993; Behan et al., 1995) . Furthermore, recent evidence indicates that at least some of these direct effects of CRH on hippocampal neurons are mediated by CRF 1 (Baram et al., 1997) .
In the absence of CRH-containing afferent projections to the hippocampus, the endogenous ligand for CRF 1 -shown here to reside primarily on pyramidal layer neurons-is likely to be CRH found in local hippocampal interneurons, as described by Swanson et al. (1983) and Sakanaka et al. (1987) . Recently most of these neurons have been found to be basket and chandelier cells, synapsing on soma and axon initial segment of pyramidal neurons, respectively (Yan et al., 1998b) . Thus, local CRH-expressing interneurons are the likely source of ligand activating the abundant CRF 1 -LI on hippocampal pyramidal layer neurons. This study documented a particularly striking density and intensity of CRF 1 immunoreactivity in CA3 pyramidal neurons. In this context, it is interesting to note that the excitatory and particularly the excitotoxic effects of CRH are maximal on CA3 hippocampal neurons (Baram and Ribak, 1995; Ribak and Baram, 1996) .
In the hypothalamus, the current study demonstrated an abundant population of generally intense CRF 1 -LI labeling of neurons in the PVN, VMH, and supraoptic and arcuate nuclei. While a small proportion (about 24%; 96 of 398) of PVN magnocellular neurons showed faint CRF 1 -LI, parvocellular neurons were very intensely labeled. Of these, most were concentrated in the anterior, medial, and lateral parts of the parvocellular division (Swanson and Kuypers, 1980; Swanson et al., 1983) . Previous studies have demonstrated that CRHexpressing parvocellular neurons of the dorsomedial division of PVN give rise to the pathway terminating in the external zone of the median eminence (Swanson et al., 1987; reviewed in Sawchenko and Swanson, 1990 ) that controls the release of ACTH from the pituitary. These CRH neurons thus participate in the control of ACTH release from the anterior pituitary, a key neuroendocrine component of the response to stress. In addition to this stress axis-related role, subpopulations of PVN CRH neurons, such as those residing in the medial and lateral parvocellular regions, project to autonomic cell groups in the brainstem and spinal cord (Sawchenko, 1987) . The current study documents the presence of CRF 1 -LI in PVN regions containing both neuroendocrine and autonomic-projecting cells. These receptors may thus be positioned to modulate both the neuroendocrine and autonomic functions of CRH.
The current study demonstrates a striking abundance of CRF 1 -LI in the PVN. This may be contrasted with previous in situ hybridization studies, showing unexpectedly little CRF 1 mRNA expression in the PVN of unstressed rats (Potter et al., 1994; Chalmers et al., 1995; Avishai-Eliner et al., 1996) . However, CRF 1 mRNA levels were highly increased by stressful manipulations (Luo et al., 1994; Rivest et al., 1995; Imaki et al., 1996; , as well as by intracere-broventricular administration of CRH. The current study demonstrated CRF 1 -LI in parvocellular neurons from hypothalami of animals obtained under relatively stress-free circumstances (see Materials and Methods) . This indicates that high CRF 1 protein levels may exist concurrent with modest steady-state CRF 1 mRNA levels. This is consistent both with a long half-life of CRF 1 and with regulation of receptor levels at the protein level. Because receptor binding studies have generally demonstrated modest levels of CRH binding in the PVN (De Souza and Kuhar, 1986) , our data may suggest increased sensitivity of the immunocytochemical approach. In agreement with our results, Radulovic et al. (1998) recently reported the presence of CRF 1 -ir neurons in PVN of both rat and mouse.
It should be noted that it is unlikely that the CRF 1 -LI observed in this study was a result of cross-reactivity with CRF 2 . Substantial homology exists between CRF 1 and CRF 2 proteins, and the immunogenic epitope used to generate the antiserum used here shares 17 of 20 amino acids with the C-terminus of CRF 2 . However, Western blotting at high antiserum concentration of mouse brain of several strains revealed a single band. In addition, the overall distribution of CRF 1 -ir in the current study matched that reported for CRF 1 binding and mRNA, and not that of CRF 2 . Finally, using the antiserum on mouse heart, known to express CRF 2 but not CRF 1 , no immunoreactivity was evident, again strongly suggesting that the antiserum does not recognize CRF 2 .
In the present study, neurons strongly labeled for CRF 1 -LI were also evident in the supraoptic nucleus. In view of the association of such neurons with CRH-expressing cells in PVN (vide supra), it is notable that a subset of supraoptic nucleus neurons have been shown to synthesize CRH (Kawata, 1983) . CRF 1 -LI was abundant in both the dorsomedial and ventromedial VMH. At the mRNA level, CRF 1 expression in the VMH has been found to be low compared with that of CRF 2 in both adult and immature animals Eghbal-Ahmadi et al., 1998) . The VMH functions to regulate food intake and energy balance. In addition, it is involved with integrating inputs from the HPA-axis, circadian rhythm, and sensory relay centers Eghbal-Ahmadi et al., 1999) . However, the relative roles of CRF 1 and CRF 2 in mediating the effects of CRH and similar ligands in the VMH are not fully understood. The relatively high levels of VMH CRF 1 -LI found in this study suggest that this receptor may participate in mediating some of the effects of CRH (and related ligands) in this region. CRF 1 -LI was abundant in monoaminergic cell groups such as the locus coeruleus, raphe, ventral tegmentum, and substantia nigra. Of these, the locus coeruleus has been shown to contain CRH-expressing neurons and fibers. A number of studies have suggested that CRH may function as a neurotransmitter in this region, involved with central integration of autonomic, behavioral, and anxiogenic effects of stressful stimuli (Valentino et al., 1992; Lehnert et al., 1998) . For example, CRH injected into the rodent locus coeruleus produces an anxiogenic response (Owens and Nemeroff, 1993) . In this regard, the present study provides an anatomical basis for the involvement of the locus ceruleus CRF 1 in mediating anxiety-related effects of CRH. CRF 1 -LI was abundant in cerebellar circuits. CRH has been localized to cerebellar mossy fiber projections originating in vestibular-related brainstem nuclei (Cha and Foote, 1988; Cummings et al., 1994) and to the climbing fibers and their origin, the inferior olive (Young et al., 1986; Cummings et al., 1994; Chang et al., 1996) . In accordance with the functional role of CRH as a cerebellar neurotransmitter, previous studies have demonstrated the expression of CRF 1 and CRF 2 mRNAs in the molecular and granular layers, sites of termination of climbing and mossy fibers, respectively (Potter et al., 1994; Chalmers et al., 1995) . In the present study, almost all Purkinje cells showed intense CRF 1 -LI, whereas these levels were generally low in both molecular and granular layers. Thus, whereas the current immunocytochemical data correlate with mRNA distribution in Purkinje cells King et al., 1997) , the current study shows low CRF 1 -LI levels in the granular layer, considered rich in CRF 1 mRNA. This apparent discrepancy may be due to the synthesis of CRF 1 within cell bodies located in the granular layer and transport of the protein away from the soma, located in the granular layer, resulting in low signal intensity in this layer (Table 3) .
The current study focused on CRF 1 detection in the mouse brain; the distribution may differ from that in rat. Thus, Radulovic et al. (1998) reported significant, although mainly quantitative, species differences in the distribution of the receptor between the rat and mouse. Compared with the rat, the mouse was found to express less CRF 1 protein in the neocortex and basal amygdala and significantly larger amounts of CRF 1 protein in several subcortical regions including the substantia nigra, central gray, red and Darkschewitsch nuclei, and pontine reticular nuclei.
In summary, the present immunocytochemical study reveals that the CRF 1 -LI is widely yet selectively expressed in the mouse brain and that its localization generally overlaps target regions of CRH projections. In addition, CRF 1 -LI distribution is generally congruent with previously published data on CRF 1 mRNA expression. However, discrepancies do exist in several regions including the central amygdaloid nucleus, septum, locus coeruleus, certain hypothalamic nuclei, and the cerebellar granular layer. These, as discussed above, may be due to differential regulation of receptor transcription and protein, to protein transport, to the cellular detail afforded by the current study, or to the presence of as yet undiscovered or cross-reacting ligands and receptors, respectively. The anti-CRF 1 antiserum recognizes a single protein species, as evident from Western blot analysis. Cell lysates were prepared from mouse hypothalamus (lanes 1 and 3) and cerebellum (lanes 2 and 4) . Aliquots of 50 µg protein were loaded in each lane. Following inclubation (see Materials and Methods), a single band of approximately 80 kDa was recognized by CRF 1 antiserum (1:500) . Lanes 3 and 4 show that preadsorption of CRF 1 antiserum with the antigenic peptide leads to disappearance of this band. Illustration of the three principal patterns of neuronal CRF 1 -like immunoreactivity (CRF 1 -LI) in mouse brain. CRF 1 -LI is characterized as granular (A, cerebellar Purkinje cells), punctate (B, parafascicular thalamic nucleus), or homogenous (arrows in C, lateral hypothalamic area). D: Preadsorption of the antiserum with the immunogenic epitope eliminates all the reaction signal (section shown is from thalamus). Scale bar = 40 µm (applies to A-D). A series of coronal sections from rostral to caudal of the paraventricular nucleus, showing neurons intensely labeled for CRF 1 -LI (A-C). Similar neurons in the supraoptic nucleus (D), arcuate nucleus and median eminence (E), and ventromedial nucleus (F). Scale bar = 80 µm (applies to A-F). Distribution of CRF 1 -like immunoreactivity in the superior (A) and inferior (B) colliculus. A few deeply labeled neurons are present in the lateral part of layer VI. In the inferior colliculus, strongly stained neurons are scattered in both the cortical and central nuclei, where most medium-sized neurons are moderately labeled. CRF 1 -LI-expressing neurons in the ventral tegmental nuclei (C), red nucleus (D), and substantia nigra (E) are strongly labeled. The accessory oculomotor nucleus (Edinger-Westphal, F) is moderately or intensely labeled, whereas the dorsal raphe nucleus (G) is rich in highly labeled neurons. Scale bar = 80 µm (applies to A-G). 
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